New Year Bumper Sale @ Rs. 1 X
Omen Act, a prescription drug, is manufactured in various forms such as Tablet. Omen Act also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Omen Act. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Omen Act also has some side effects, the most common being Upper respiratory tract infection, Loss of appetite, Gastric Irritation. Apart from the aforementioned side effects, Omen Act can also lead to other problems, which have been listed below. Such side effects of Omen Act normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Omen Act has a Mild effect for pregnant women and Mild effect on lactating mothers. It is important to know if Omen Act has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Omen Act related warnings section.
Omen Act can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Omen Act in conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension). Other contraindications of Omen Act have been discussed in the sections ahead.
Drug interactions for Omen Act have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Omen Act is considered not safe while driving, and is not addictive.
Omen Act is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Omen Act safe for pregnant women?
Pregnant women can consume [medicine]. Though Omen Act has mild side effects when taken during pregnany
Is the use of Omen Act safe during breastfeeding?
Side effects of Omen Act for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Omen Act on the Kidneys?
Very few cases of side effects of Omen Act on kidney have been reported.
What is the effect of Omen Act on the Liver?
Very few cases of side effects of Omen Act on the liver have been reported.
What is the effect of Omen Act on the Heart?
Side effects of Omen Act rarely affect the heart.
Omen Act should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Omen Act unless your doctor advises you to do so -
Is this Omen Act habit forming or addictive?
No, you will not get addicted to Omen Act.
Interaction between Food and Omen Act
When consumed with certain foods, Omen Act may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Omen Act
Consumption of alcohol and Omen Act together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448